See What HealthDay Can Do For You
Contact Us

Clinical Trials Update: Nov. 18, 2003

Diabetic Neuropathy Lung Cancer Ovarian Cancer

(HealthDayNews) -- Here are the latest clinical trials, courtesy of CenterWatch:

Diabetic Neuropathy

A study to assess the safety and efficacy of an investigational medication in people with neuropathic pain associated with diabetic neuropathy. Volunteers at least 18 who have diabetes mellitus (type I or II) that is controlled by oral or parenteral hypoglycemic agents or diet and who have a diagnosis of painful diabetic distal symmetric sensory/motor polyneuropathy may be eligible. Research sites located throughout the United States.

More Information

Please see http://www.centerwatch.com/patient/studies/cat253.html.

-----

Lung Cancer

A study to assess the safety and efficacy of an investigational medication in people with advanced non-small cell lung cancer. Volunteers with a histologic and/or cytologic diagnosis of locally-advanced or metastatic non-small cell lung cancer who are not curable by conventional therapy may be eligible. Research sites located throughout the United States.

More Information

Please see http://www.centerwatch.com/patient/studies/cat34.html.

-----

Ovarian Cancer

A study of an investigational medication for patients with ovarian cancer. Female volunteers at least 18 years old who have a diagnosis of epithelial cancer of the ovary, fallopian tube or primary peritoneal cancer and whose cancer has progressed after platinum-based chemotherapy may be eligible. Research sites located throughout the United States.

More Information

Please see http://www.centerwatch.com/patient/studies/cat186.html.

-----

Copyright 2003 CenterWatch. All rights reserved.

Consumer News